XML 36 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss), Derivative Qualifying as Hedge, Excluded Component, Including Portion Attributable to Noncontrolling Interest
Retained Earnings
Balance at the beginning at Dec. 31, 2020 $ 47,293 $ 2 $ 135,292   $ (88,001)
Balance at the beginning (in shares) at Dec. 31, 2020   18,257,000      
Issuance of common stock upon Business Combination and PIPE Financing, net of transaction costs and warrant liabilities 114,465 $ 2 114,463    
Issuance of common stock upon Business Combination and PIPE Financing, net of issuance costs and warrant liabilities, shares   16,441,000      
Exercises of stock options 411   411    
Exercises of stock options, shares   161,000      
Reclassification to liability for early exercised stock options (225)   (225)    
Vesting of early exercised stock options 207   207    
Repurchase of early exercised stock options, shares   (1,000)      
Repurchase and cancelation of common stock 0        
Restricted stock granted, shares   193,000      
Restricted stock forfeited, shares   (16,000)      
Stock-based compensation expense 2,316   2,316    
Other comprehensive loss (119)     $ (119)  
Net loss (54,648)       (54,648)
Balance at the end at Dec. 31, 2021 109,700 $ 4 252,464 (119) (142,649)
Balance at the end (in shares) at Dec. 31, 2021   35,034,000      
Reclassification to liability for early exercised stock options 101   101    
Repurchase of early exercised stock options, shares   (11,000)      
Issuance of common stock under Equity Purchase Agreement(Value) 273   273    
Issuance of common stock under Equity Purchase Agreement (Share)   100,000      
Issuance of common stock under employee stock purchase plan (Share)   347,000      
Issuance of common stock under employee stock purchase plan 143   143    
Repurchase and cancelation of common stock (2,607) $ (1) (2,606)    
Repurchase and cancellation of common stock (Share)   (5,382,000)      
Stock-based compensation expense 4,517   4,517    
Other comprehensive loss (122)     (122)  
Net loss (36,004)       (36,004)
Balance at the end at Dec. 31, 2022 $ 76,001 $ 3 $ 254,892 $ (241) $ (178,653)
Balance at the end (in shares) at Dec. 31, 2022   30,088,000